<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-03868</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0070656</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories>
<title-group>
<article-title>The Associations of Single Nucleotide Polymorphisms in miR-146a, miR-196a and miR-499 with Breast Cancer Susceptibility</article-title>
<alt-title alt-title-type="running-head">microRNAs and Breast Cancer Susceptibility</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>Ping-Yu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gao</surname><given-names>Zong-Hua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiang</surname><given-names>Zhong-Hua</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Xin-Xin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiang</surname><given-names>Bao-Fa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Xie</surname><given-names>Shu-Yang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Epidemiology, Binzhou Medical University, YanTai, ShanDong, P.R. China</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Epidemiology, School of Public Health, Shandong University, JiNan, ShanDong, P.R. China</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Imaging, Yantai Traditional Chinese Medical Science Hospital, YanTai, ShanDong, P.R. China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Mittal</surname><given-names>Balraj</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Sanjay Gandhi Medical Institute, India</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">bjiang@sdu.edu.cn</email> (BFJ); <email xlink:type="simple">shuyangxie@aliyun.com</email> (SYJ)</corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: PYW SYX. Performed the experiments: PYW ZHG ZHJ XXL. Analyzed the data: PYW XXL. Contributed reagents/materials/analysis tools: SYX BFJ. Wrote the paper: PYW BFJ SYX.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>9</day><month>9</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>9</issue>
<elocation-id>e70656</elocation-id>
<history>
<date date-type="received"><day>23</day><month>1</month><year>2013</year></date>
<date date-type="accepted"><day>20</day><month>6</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Wang et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract><sec>
<title>Background</title>
<p>Previous studies have investigated the association between single nucleotide polymorphisms (SNPs) located in microRNAs (miRNAs) and breast cancer susceptibility; however, because of their limited statistical power, many discrepancies are revealed in these studies. The meta-analysis presented here aimed to identify and characterize the roles of miRNA SNPs in breast cancer risk, and evaluate the associations of polymorphisms in miR-146a rs2910164, miR-196a rs11614913 and miR-499 rs3746444 with breast cancer susceptibility, respectively.</p>
</sec><sec>
<title>Methodology/Principal Findings</title>
<p>The PubMed and Embases databases were searched updated to 31<sup>st</sup> December, 2012. The complete data of polymorphisms in miR-146a rs2910164, miR-196a rs11614913 and miR-499 rs3746444 from case-control studies for breast cancer were analyzed by odds ratios (ORs) with 95% confidence intervals (CIs) to reveal the associations of SNPs in miRNAs with breast cancer susceptibility. Totally, six studies for rs2910164 in miR-146a, involving 4225 cases and 4469 controls; eight studies for rs11614913 in miR-196a, involving 4110 cases and 5100 controls; and three studies of rs3746444 in miR-499, involving 2588 cases and 3260 controls, were investigated in the meta-analysis. The rs11614913 (TT+CT) genotype of miR-196a2 was revealed to be associated with a decreased breast cancer susceptibility compared with the CC genotypes (OR = 0.906, 95% CI: 0.825–0.995, <italic>P</italic> = 0.039); however, no significant associations were observed between rs2910164 in miR-146a (or rs3746444 in miR-499) and breast cancer susceptibility.</p>
</sec><sec>
<title>Conclusions</title>
<p>This meta-analysis demonstrates the compelling evidence that the rs11614913 CC genotype in miR-196a2 increases breast cancer risk, which provides useful information for the early diagnosis and prevention of breast cancer.</p>
</sec></abstract>
<funding-group><funding-statement>This study was partly supported by the Program for New Century Excellent Talents in University (NCET-10-0919), and National Natural Science Foundation of China (No. 81141114, 81200601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>MicroRNAs (miRNAs) are non-coding RNA molecules that can act as tumor suppressor genes or oncogenes <xref ref-type="bibr" rid="pone.0070656-EsquelaKerscher1">[1]</xref>. There are more than 1000 miRNA genes in the human genome <xref ref-type="bibr" rid="pone.0070656-Bartels1">[2]</xref>–<xref ref-type="bibr" rid="pone.0070656-Rosenfeld1">[4]</xref>, which regulate the translation or degradation of human messenger RNA (mRNA) by sequence complementarity <xref ref-type="bibr" rid="pone.0070656-Berezikov1">[5]</xref>–<xref ref-type="bibr" rid="pone.0070656-Zamore1">[7]</xref>. MiRNAs regulate approximately 30% of human genes <xref ref-type="bibr" rid="pone.0070656-Carthew1">[8]</xref>. The genetic variants of a miRNA may affect its biogenesis and maturation <xref ref-type="bibr" rid="pone.0070656-Calin1">[9]</xref>, <xref ref-type="bibr" rid="pone.0070656-Jazdzewski1">[10]</xref>, which are causally linked to the pathogenesis of numerous diseases, including cancer <xref ref-type="bibr" rid="pone.0070656-Lin1">[11]</xref>, <xref ref-type="bibr" rid="pone.0070656-Ryan1">[12]</xref>.</p>
<p>Several miRNA polymorphisms have been reported to affect miRNA processing or miRNA-mRNA interactions <xref ref-type="bibr" rid="pone.0070656-Ryan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0070656-Ye1">[13]</xref>. Single nucleotide polymorphisms (SNPs) in miRNAs can be used as genetic markers to predict breast cancer susceptibility or prognosis. For example, a significant association was identified between polymorphism rs11614913 in miR-196a2 and breast cancer risk <xref ref-type="bibr" rid="pone.0070656-Alshatwi1">[14]</xref>. Breast cancer patients with the variant C allele in miR-146a produced higher levels of mature miR-146, which may predispose women to an earlier age of onset of familial breast cancer <xref ref-type="bibr" rid="pone.0070656-Pastrello1">[15]</xref>, <xref ref-type="bibr" rid="pone.0070656-Shen1">[16]</xref>. The variant genotypes rs3746444 in miR-499 were also reported to be associated with significantly increased risks of breast cancer <xref ref-type="bibr" rid="pone.0070656-Hu1">[17]</xref>. The rs6505162 with the CC genotype in miR-423 could reduce the risk of breast cancer development <xref ref-type="bibr" rid="pone.0070656-Smith1">[18]</xref>. Nevertheless, some SNPs in miRNAs showed no association with breast cancer risk <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>, <xref ref-type="bibr" rid="pone.0070656-Jedlinski1">[20]</xref>. Catucci <italic>et al.</italic> reported that the SNPs rs11614913 in miR-196a2, rs3746444 in mir-499 and rs2910164 in miR-146a were not related to breast cancer risk <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>. Jedlinski's study also did not support the association of polymorphism rs11614913 in miR-196a2 with breast cancer susceptibility <xref ref-type="bibr" rid="pone.0070656-Jedlinski1">[20]</xref>. Thus, there are many discrepancies concerning the relationship between SNPs in miRNA (miR-146a, miR-196a2, and miR-499) and breast cancer susceptibility, which may be attributed to sample sizes, different ethnic group and different miRNAs studied.</p>
<p>Meta-analysis is statistical methods for contrasting and combining results from different studies, in the hope of identifying sources of disagreement among those results <xref ref-type="bibr" rid="pone.0070656-Greenland1">[21]</xref>. A meta-analysis allows derivation and statistical testing of overall factors and effect-size parameters, which can identify whether a publication bias exists or whether the results are more varied than what is expected from the sample diversity. Though several meta-analysis studies evaluating the roles of miRNA gene polymorphisms in cancer have been published, few meta-analysis studies have assessed the associations of three SNPs of miR-146a, miR-196a and miR-499 with breast cancer susceptibility. Therefore, we selected these three SNPs in this meta-analysis, according to two basic principles as established in a previous study <xref ref-type="bibr" rid="pone.0070656-Zhang1">[22]</xref>: first, the minor allele frequency of the SNP was not less than 5%; Secondly, only functional SNPs were selected. This meta-analysis aimed to resolve the discrepancies among the results of the associations of these miRNAs (miR-146a, miR-196a2, and miR-499) with breast cancer susceptibility.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Eligible studies and data extraction</title>
<p>PubMed and Embases databases were searched with the following terms: “breast cancer/carcinoma”, “polymorphism/variant”, “miR-146a/rs2910164”, “miR-196a2/rs11614913” or “miR-499/rs3746444”. The searched articles, published in English language updated to 31<sup>st</sup> December, 2012, were limited to human species, female sex and cancer subjects of adult patients (19+ years). All the titles and abstracts of searched articles were reviewed to exclude clearly irrelevant studies. The full texts of the remaining articles were read, and a manual search of the references from original studies was performed to identify additional articles of the same topic.</p>
<p>All the case-control studies were studied according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) as a previous report <xref ref-type="bibr" rid="pone.0070656-Vandenbroucke1">[23]</xref>. The specific inclusion criteria as follows: (1) Case-control studies: cases are patients newly diagnosed with breast cancer, and the controls were subjects without breast cancer; (2) Odds ratios (ORs) with their 95% confidence intervals (95% CIs) are calculated from correct and sufficient polymorphism distribution data; (3) Correct statistical analysis. The strict exclusion criteria were: (1) Pure cell studies, non-breast cancer studies; (2) Articles that are not case-control studies; (3) Repeated or overlapped studies; (4) Articles with obvious mistakes.</p>
<p>Two reviewers (Zong-Hua Gao and Xin-Xin Li) extracted data independently using standardized forms. The following characteristics were collected from each study if available: (1) publication year; (2) first author's name; (3) country origin; (4) ethnicity were categorized as Caucasian, and non-Caucasian; (5) genotyping methods; (6) total numbers of cases and controls; (7) miR-146a, miR-196a and miR-499 polymorphism distribution data, respectively; (8) <italic>P</italic> value for Hardy-Weinberg equilibrium (HWE) of controls. In case of disagreement, another reviewer (Zhong-Hua Jiang) resolved these disagreements according to the original data.</p>
</sec><sec id="s2b">
<title>Statistical analysis</title>
<p>Deviation in the controls of all studies from HWE tests were carried out online using a web-based program (<ext-link ext-link-type="uri" xlink:href="http://ihg.gsf.de/cgi-bin/hw/hwa1.pl" xlink:type="simple">http://ihg.gsf.de/cgi-bin/hw/hwa1.pl</ext-link>), and <italic>P</italic> value &lt;0.05 was considered significant. The ORs with their corresponding 95% CIs (homozygote comparison, heterozygote comparison, dominant model and recessive model, respectively) were calculated to analyze the associations of polymorphisms (rs2910164 in miR-146, rs11614913 in miR-196a2 and rs3746444 in miR-499) with breast cancer susceptibility. The significance of the pooled ORs was checked by the <italic>Z</italic> test, and statistical significance was defined as <italic>P</italic> value &lt;0.05.</p>
<p>Cochran <italic>Q</italic> test and estimating <italic>I<sup>2</sup></italic> test were used to evaluate whether the results from these studies were homogeneous <xref ref-type="bibr" rid="pone.0070656-Higgins1">[24]</xref>, <xref ref-type="bibr" rid="pone.0070656-Ioannidis1">[25]</xref>. For Cochran <italic>Q</italic> test, <italic>P</italic> value &lt;0.10 suggests heterogeneity among studies. As <italic>I<sup>2</sup></italic> test, <italic>I<sup>2</sup></italic> value &lt;40% indicates “not important heterogeneity”, while a value &gt;75% shows “considerable heterogeneity”. If presence of heterogeneity, the random effects model (DerSimonian Laird) was chosen. Otherwise, the fixed effects model (Mantel-Haenszel) was appropriately used to calculate the pooled ORs.</p>
<p>Publication bias was evaluated using the Begg-Mazumdar adjusted rank correlation test and the Egger regression asymmetry test, <italic>P</italic> value &lt;0.10 was considered as the representative of statistically significant publication bias <xref ref-type="bibr" rid="pone.0070656-Begg1">[26]</xref>, <xref ref-type="bibr" rid="pone.0070656-Egger1">[27]</xref>. Sensitivity analysis was carried to assess the stability of these results. All Statistical analyses were carried out using STATA 11.0 software (STATA Corp, College Station, TX, USA).</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Characteristics of studies</title>
<p>Eligible studies were selected according to the inclusion and exclusion criteria (<xref ref-type="fig" rid="pone-0070656-g001">Figure 1</xref>). Thirty-one records were excluded by reviewing article titles and abstracts, including 16 records that did not focus on breast cancer and 15 records that were systematic reviews. Then, 14 full texts and related reference lists were read. Five records were excluded: 2 records were not case-control studies and 3 records were breast cancer diagnosis and therapy studies. The article published by Alshatwi contained discrepancies between the data shown in the tables and the data described in the results section <xref ref-type="bibr" rid="pone.0070656-Alshatwi1">[14]</xref>; therefore, after consultation with the author, these data were excluded. In Catucci's <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref> and Linhares's <xref ref-type="bibr" rid="pone.0070656-Linhares1">[28]</xref> studies, the genotype frequencies were presented according to the subjects' country or race, as in previous reports <xref ref-type="bibr" rid="pone.0070656-Wang1">[29]</xref>, <xref ref-type="bibr" rid="pone.0070656-Chu1">[30]</xref>; thus in the present analysis each group was considered as an independent study. Moreover, in some included articles, if two or more miRNA SNPs were investigated in an article, each miRNA SNP was considered as an independent study. Therefore, six studies, involving 4225 cases and 4469 controls, were ultimately analyzed for the SNP (rs2910164) in miR-146a <xref ref-type="bibr" rid="pone.0070656-Pastrello1">[15]</xref>, <xref ref-type="bibr" rid="pone.0070656-Hu1">[17]</xref>, <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>, <xref ref-type="bibr" rid="pone.0070656-Garcia1">[31]</xref>, <xref ref-type="bibr" rid="pone.0070656-Hoffman1">[32]</xref>; eight studies, involving 4110 cases and 5100 controls, were performed for rs11614913 in miR-196a <xref ref-type="bibr" rid="pone.0070656-Hu1">[17]</xref>, <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>, <xref ref-type="bibr" rid="pone.0070656-Jedlinski1">[20]</xref>, <xref ref-type="bibr" rid="pone.0070656-Zhang1">[22]</xref>, <xref ref-type="bibr" rid="pone.0070656-Linhares1">[28]</xref>, <xref ref-type="bibr" rid="pone.0070656-Hoffman1">[32]</xref>; and three studies, involving 2588 cases and 3260 controls, were tested for rs3746444 in miR-499 <xref ref-type="bibr" rid="pone.0070656-Hu1">[17]</xref>, <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>, respectively.</p>
<fig id="pone-0070656-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070656.g001</object-id><label>Figure 1</label><caption>
<title>Flow diagram of selection of studies with criteria for inclusion and exclusion.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070656.g001" position="float" xlink:type="simple"/></fig>
<p>Characteristics of the included studies were shown in <xref ref-type="table" rid="pone-0070656-t001">Table 1</xref>. These studies were published from year 2009 to 2012. The subjects came from different countries (Australia, Brazil, China, France, Germany, Italy, and USA). Ethnicity was categorized as Caucasians or non-Caucasians population. Genotyping methods included polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), TaqMan SNP genotyping assay and MassArray multiplex. Blood samples were used for genotyping in most studies. HWE was assessed by a chi-square test. The distribution of genotypes in the controls agreed with HWE (<italic>P</italic>&gt;0.05) in most of the studies, but some parts of the data in Catucci's <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref> and Linhares's <xref ref-type="bibr" rid="pone.0070656-Linhares1">[28]</xref> studies significantly departed from HWE (<italic>P</italic>&lt;0.05). Begg-Mazumdar adjusted rank correlation test and the Egger regression asymmetry test were used to assess the publication bias of the currently available literature.</p>
<table-wrap id="pone-0070656-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070656.t001</object-id><label>Table 1</label><caption>
<title>Characteristics of the studies in the meta-analysis.</title>
</caption><alternatives><graphic id="pone-0070656-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070656.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Study</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td align="left" rowspan="1" colspan="1">Genotyping method</td>
<td align="left" rowspan="1" colspan="1">Case</td>
<td align="left" rowspan="1" colspan="1">Control</td>
<td colspan="3" align="left" rowspan="1">Case</td>
<td colspan="3" align="left" rowspan="1">Control</td>
<td align="left" rowspan="1" colspan="1">P<sub>HWE</sub></td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1">miR-146a rs2910164</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">CG</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">CG</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Garcia et al</td>
<td align="left" rowspan="1" colspan="1">France</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">1130</td>
<td align="left" rowspan="1" colspan="1">596</td>
<td align="left" rowspan="1" colspan="1">676</td>
<td align="left" rowspan="1" colspan="1">388</td>
<td align="left" rowspan="1" colspan="1">66</td>
<td align="left" rowspan="1" colspan="1">352</td>
<td align="left" rowspan="1" colspan="1">220</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">0.150</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Catucci et al</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">805</td>
<td align="left" rowspan="1" colspan="1">904</td>
<td align="left" rowspan="1" colspan="1">451</td>
<td align="left" rowspan="1" colspan="1">304</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">536</td>
<td align="left" rowspan="1" colspan="1">318</td>
<td align="left" rowspan="1" colspan="1">50</td>
<td align="left" rowspan="1" colspan="1">0.753</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Catucci et al</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">754</td>
<td align="left" rowspan="1" colspan="1">1243</td>
<td align="left" rowspan="1" colspan="1">409</td>
<td align="left" rowspan="1" colspan="1">286</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">650</td>
<td align="left" rowspan="1" colspan="1">520</td>
<td align="left" rowspan="1" colspan="1">73</td>
<td align="left" rowspan="1" colspan="1">0.019</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Pastrello et al</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">88</td>
<td align="left" rowspan="1" colspan="1">155</td>
<td align="left" rowspan="1" colspan="1">53</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">90</td>
<td align="left" rowspan="1" colspan="1">59</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">0.332</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Hoffman et al</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">MassARRAY</td>
<td align="left" rowspan="1" colspan="1">439</td>
<td align="left" rowspan="1" colspan="1">478</td>
<td align="left" rowspan="1" colspan="1">234</td>
<td align="left" rowspan="1" colspan="1">176</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">273</td>
<td align="left" rowspan="1" colspan="1">178</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">0.775</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Hu et al</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">non-Caucasian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">1009</td>
<td align="left" rowspan="1" colspan="1">1093</td>
<td align="left" rowspan="1" colspan="1">165</td>
<td align="left" rowspan="1" colspan="1">515</td>
<td align="left" rowspan="1" colspan="1">329</td>
<td align="left" rowspan="1" colspan="1">180</td>
<td align="left" rowspan="1" colspan="1">551</td>
<td align="left" rowspan="1" colspan="1">362</td>
<td align="left" rowspan="1" colspan="1">0.221</td>
</tr>
</tbody>
</table>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td colspan="3" align="left" rowspan="1">miR-196a2 rs11614913</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">CT</td>
<td align="left" rowspan="1" colspan="1">TT</td>
<td align="left" rowspan="1" colspan="1">CC</td>
<td align="left" rowspan="1" colspan="1">CT</td>
<td align="left" rowspan="1" colspan="1">TT</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Zhang et al</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">non-Caucasian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">248</td>
<td align="left" rowspan="1" colspan="1">243</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">89</td>
<td align="left" rowspan="1" colspan="1">148</td>
<td align="left" rowspan="1" colspan="1">17</td>
<td align="left" rowspan="1" colspan="1">93</td>
<td align="left" rowspan="1" colspan="1">133</td>
<td align="left" rowspan="1" colspan="1">0.893</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Linhares et al</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">non-Caucasian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">63</td>
<td align="left" rowspan="1" colspan="1">114</td>
<td align="left" rowspan="1" colspan="1">11</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">23</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">51</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td align="left" rowspan="1" colspan="1">0.264</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Linhares et al</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">325</td>
<td align="left" rowspan="1" colspan="1">274</td>
<td align="left" rowspan="1" colspan="1">83</td>
<td align="left" rowspan="1" colspan="1">148</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">94</td>
<td align="left" rowspan="1" colspan="1">114</td>
<td align="left" rowspan="1" colspan="1">66</td>
<td align="left" rowspan="1" colspan="1">0.008</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Jedlinski et al</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">187</td>
<td align="left" rowspan="1" colspan="1">171</td>
<td align="left" rowspan="1" colspan="1">68</td>
<td align="left" rowspan="1" colspan="1">86</td>
<td align="left" rowspan="1" colspan="1">33</td>
<td align="left" rowspan="1" colspan="1">58</td>
<td align="left" rowspan="1" colspan="1">82</td>
<td align="left" rowspan="1" colspan="1">31</td>
<td align="left" rowspan="1" colspan="1">0.830</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Catucci et al</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">1101</td>
<td align="left" rowspan="1" colspan="1">1496</td>
<td align="left" rowspan="1" colspan="1">432</td>
<td align="left" rowspan="1" colspan="1">512</td>
<td align="left" rowspan="1" colspan="1">157</td>
<td align="left" rowspan="1" colspan="1">584</td>
<td align="left" rowspan="1" colspan="1">696</td>
<td align="left" rowspan="1" colspan="1">216</td>
<td align="left" rowspan="1" colspan="1">0.711</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Catucci et al</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">751</td>
<td align="left" rowspan="1" colspan="1">1243</td>
<td align="left" rowspan="1" colspan="1">334</td>
<td align="left" rowspan="1" colspan="1">330</td>
<td align="left" rowspan="1" colspan="1">87</td>
<td align="left" rowspan="1" colspan="1">532</td>
<td align="left" rowspan="1" colspan="1">550</td>
<td align="left" rowspan="1" colspan="1">161</td>
<td align="left" rowspan="1" colspan="1">0.315</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Hoffman et al</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">MassARRAY</td>
<td align="left" rowspan="1" colspan="1">426</td>
<td align="left" rowspan="1" colspan="1">466</td>
<td align="left" rowspan="1" colspan="1">181</td>
<td align="left" rowspan="1" colspan="1">209</td>
<td align="left" rowspan="1" colspan="1">36</td>
<td align="left" rowspan="1" colspan="1">166</td>
<td align="left" rowspan="1" colspan="1">229</td>
<td align="left" rowspan="1" colspan="1">71</td>
<td align="left" rowspan="1" colspan="1">0.583</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Hu et al</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">non-Caucasian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">1009</td>
<td align="left" rowspan="1" colspan="1">1093</td>
<td align="left" rowspan="1" colspan="1">239</td>
<td align="left" rowspan="1" colspan="1">483</td>
<td align="left" rowspan="1" colspan="1">287</td>
<td align="left" rowspan="1" colspan="1">218</td>
<td align="left" rowspan="1" colspan="1">517</td>
<td align="left" rowspan="1" colspan="1">358</td>
<td align="left" rowspan="1" colspan="1">0.210</td>
</tr>
</tbody>
</table>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td colspan="3" align="left" rowspan="1">mir-499 rs3746444</td>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">AG</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1">GG</td>
<td align="left" rowspan="1" colspan="1">AG</td>
<td align="left" rowspan="1" colspan="1">AA</td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Catucci et al</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">823</td>
<td align="left" rowspan="1" colspan="1">925</td>
<td align="left" rowspan="1" colspan="1">37</td>
<td align="left" rowspan="1" colspan="1">250</td>
<td align="left" rowspan="1" colspan="1">536</td>
<td align="left" rowspan="1" colspan="1">34</td>
<td align="left" rowspan="1" colspan="1">290</td>
<td align="left" rowspan="1" colspan="1">601</td>
<td align="left" rowspan="1" colspan="1">0.893</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Catucci et al</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Caucasian</td>
<td align="left" rowspan="1" colspan="1">Taqman</td>
<td align="left" rowspan="1" colspan="1">756</td>
<td align="left" rowspan="1" colspan="1">1242</td>
<td align="left" rowspan="1" colspan="1">47</td>
<td align="left" rowspan="1" colspan="1">295</td>
<td align="left" rowspan="1" colspan="1">414</td>
<td align="left" rowspan="1" colspan="1">86</td>
<td align="left" rowspan="1" colspan="1">452</td>
<td align="left" rowspan="1" colspan="1">704</td>
<td align="left" rowspan="1" colspan="1">0.250</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Hu et al</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Asian</td>
<td align="left" rowspan="1" colspan="1">PCR-RFLP</td>
<td align="left" rowspan="1" colspan="1">1009</td>
<td align="left" rowspan="1" colspan="1">1093</td>
<td align="left" rowspan="1" colspan="1">44</td>
<td align="left" rowspan="1" colspan="1">258</td>
<td align="left" rowspan="1" colspan="1">707</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">248</td>
<td align="left" rowspan="1" colspan="1">816</td>
<td align="left" rowspan="1" colspan="1">0.057</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap></sec><sec id="s3b">
<title>Main results</title>
<p>The meta-analysis results of the three SNPs in the miRNAs and breast cancer risk were shown in <xref ref-type="table" rid="pone-0070656-t002">Table 2</xref>. There were no significant associations between polymorphisms rs2910164 in miR-146a and breast cancer susceptibility for all genetic models. Because the data for the Italy population group in Catucci's study <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref> significantly departed from HWE (<italic>P</italic> = 0.019), we deleted the data to analyze the associations of rs2910164 in miR-146a with breast cancer susceptibility; no significant risk associations were observed between them.</p>
<table-wrap id="pone-0070656-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070656.t002</object-id><label>Table 2</label><caption>
<title>Meta-analysis results for the four polymorphisms and breast cancer risk. (OR, odds ratio; CI, confidence interval.)</title>
</caption><alternatives><graphic id="pone-0070656-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070656.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Has-mir-146a (rs2910164)</td>
<td align="left" rowspan="1" colspan="1">No. of studies</td>
<td align="left" rowspan="1" colspan="1">Sample size (cases/controls)</td>
<td align="left" rowspan="1" colspan="1">?2</td>
<td align="left" rowspan="1" colspan="1">P<sub>-H</sub></td>
<td align="left" rowspan="1" colspan="1"><italic>I<sup>2</sup></italic>(%)</td>
<td align="left" rowspan="1" colspan="1">Model</td>
<td align="left" rowspan="1" colspan="1">OR(95%CI)</td>
<td align="left" rowspan="1" colspan="1">z</td>
<td align="left" rowspan="1" colspan="1">P<sub>-z</sub></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">C vs G</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">4225/4469</td>
<td align="left" rowspan="1" colspan="1">2.29</td>
<td align="left" rowspan="1" colspan="1">0.808</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.036(0.968–1.108)</td>
<td align="left" rowspan="1" colspan="1">1.02</td>
<td align="left" rowspan="1" colspan="1">0.308</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CC vs GG</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">4225/4469</td>
<td align="left" rowspan="1" colspan="1">2.63</td>
<td align="left" rowspan="1" colspan="1">0.757</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.156(0.980–1.364)</td>
<td align="left" rowspan="1" colspan="1">1.72</td>
<td align="left" rowspan="1" colspan="1">0.085</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CC vs CG</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">4225/4469</td>
<td align="left" rowspan="1" colspan="1">6.26</td>
<td align="left" rowspan="1" colspan="1">0.282</td>
<td align="left" rowspan="1" colspan="1">20.1</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.103(0.955–1.274)</td>
<td align="left" rowspan="1" colspan="1">1.33</td>
<td align="left" rowspan="1" colspan="1">0.183</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CG+CC vs GG</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">4225/4469</td>
<td align="left" rowspan="1" colspan="1">3.92</td>
<td align="left" rowspan="1" colspan="1">0.562</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.022(0.932–1.120)</td>
<td align="left" rowspan="1" colspan="1">0.46</td>
<td align="left" rowspan="1" colspan="1">0.644</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CC vs GG+CG</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">4225/4469</td>
<td align="left" rowspan="1" colspan="1">4.80</td>
<td align="left" rowspan="1" colspan="1">0.441</td>
<td align="left" rowspan="1" colspan="1">0.0</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.102(0.960–1.264)</td>
<td align="left" rowspan="1" colspan="1">1.38</td>
<td align="left" rowspan="1" colspan="1">0.168</td>
</tr>
<tr>
<td colspan="10" align="left" rowspan="1">has-mir-196a (rs11614913)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">T vs C</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">4110/5100</td>
<td align="left" rowspan="1" colspan="1">25.36</td>
<td align="left" rowspan="1" colspan="1">0.001</td>
<td align="left" rowspan="1" colspan="1">72.5</td>
<td align="left" rowspan="1" colspan="1">R</td>
<td align="left" rowspan="1" colspan="1">0.994(0.875,1.129)</td>
<td align="left" rowspan="1" colspan="1">0.10</td>
<td align="left" rowspan="1" colspan="1">0.924</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TT vs CC</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">4110/5100</td>
<td align="left" rowspan="1" colspan="1">25.65</td>
<td align="left" rowspan="1" colspan="1">0.001</td>
<td align="left" rowspan="1" colspan="1">72.7</td>
<td align="left" rowspan="1" colspan="1">R</td>
<td align="left" rowspan="1" colspan="1">0.970(0.738–1.275)</td>
<td align="left" rowspan="1" colspan="1">0.22</td>
<td align="left" rowspan="1" colspan="1">0.828</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CT vs CC</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">4110/5100</td>
<td align="left" rowspan="1" colspan="1">9.97</td>
<td align="left" rowspan="1" colspan="1">0.190</td>
<td align="left" rowspan="1" colspan="1">29.8</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">0.970(0.882–1.067)</td>
<td align="left" rowspan="1" colspan="1">0.63</td>
<td align="left" rowspan="1" colspan="1">0.530</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TT vs CT+CC</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">4110/5100</td>
<td align="left" rowspan="1" colspan="1">17.68</td>
<td align="left" rowspan="1" colspan="1">0.013</td>
<td align="left" rowspan="1" colspan="1">60.4</td>
<td align="left" rowspan="1" colspan="1">R</td>
<td align="left" rowspan="1" colspan="1">0.952(0.791–1.147)</td>
<td align="left" rowspan="1" colspan="1">0.51</td>
<td align="left" rowspan="1" colspan="1">0.609</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">TT+CT vs CC</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">4110/5100</td>
<td align="left" rowspan="1" colspan="1">17.83</td>
<td align="left" rowspan="1" colspan="1">0.013</td>
<td align="left" rowspan="1" colspan="1">60.7</td>
<td align="left" rowspan="1" colspan="1">R</td>
<td align="left" rowspan="1" colspan="1">0.987(0.836–1.165)</td>
<td align="left" rowspan="1" colspan="1">0.15</td>
<td align="left" rowspan="1" colspan="1">0.877</td>
</tr>
<tr>
<td colspan="10" align="left" rowspan="1">has-mir-499 (rs3746444)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">G vs A</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2588/3260</td>
<td align="left" rowspan="1" colspan="1">4.34</td>
<td align="left" rowspan="1" colspan="1">0.114</td>
<td align="left" rowspan="1" colspan="1">53.9</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.100(0.960–1.260)</td>
<td align="left" rowspan="1" colspan="1">1.37</td>
<td align="left" rowspan="1" colspan="1">0.171</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">GG vs AA</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2588/3260</td>
<td align="left" rowspan="1" colspan="1">4.17</td>
<td align="left" rowspan="1" colspan="1">0.124</td>
<td align="left" rowspan="1" colspan="1">52.0</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.194(0.931–1.532)</td>
<td align="left" rowspan="1" colspan="1">1.40</td>
<td align="left" rowspan="1" colspan="1">0.162</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">AG vs AA</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2588/3260</td>
<td align="left" rowspan="1" colspan="1">2.24</td>
<td align="left" rowspan="1" colspan="1">0.327</td>
<td align="left" rowspan="1" colspan="1">10.6</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.090(0.972–1.223)</td>
<td align="left" rowspan="1" colspan="1">1.48</td>
<td align="left" rowspan="1" colspan="1">0.139</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">GG vs AA+AG</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2588/3260</td>
<td align="left" rowspan="1" colspan="1">4.31</td>
<td align="left" rowspan="1" colspan="1">0.116</td>
<td align="left" rowspan="1" colspan="1">53.5</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.156(0.905–1.477)</td>
<td align="left" rowspan="1" colspan="1">1.16</td>
<td align="left" rowspan="1" colspan="1">0.247</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">GG+AG vs AA</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">2588/3260</td>
<td align="left" rowspan="1" colspan="1">2.95</td>
<td align="left" rowspan="1" colspan="1">0.229</td>
<td align="left" rowspan="1" colspan="1">32.1</td>
<td align="left" rowspan="1" colspan="1">F</td>
<td align="left" rowspan="1" colspan="1">1.107(0.992–1.235)</td>
<td align="left" rowspan="1" colspan="1">1.81</td>
<td align="left" rowspan="1" colspan="1">0.070</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap>
<p>When all the studies concerning SNP rs11614913 in miR-196a2 were pooled into this meta-analysis, no significant breast cancer risk was observed for any SNP genotype of miR-196a2. After excluding the Linhares's study <xref ref-type="bibr" rid="pone.0070656-Linhares1">[28]</xref>, in which the distribution of miR-196a2 genotypes in controls deviated from the HWE (<italic>P</italic> = 0.008) and the included population was mixed, we found that the heterogeneities of the miR-196a2 SNP data were reduced and the genotypic results were more credible. In the comparision of genotypes (TT+CT) <italic>vs</italic> CC, obvious heterogeneity (Heterogeneity chi-square test = 17.83, <italic>P-<sub>Het</sub></italic> = 0.013, <italic>I<sup>2</sup></italic> = 60.7%) was reduced to little heterogeneity (Heterogeneity chi-square test = 6.70, <italic>P</italic>-<italic><sub>Het</sub></italic> = 0.244, <italic>I<sup>2</sup></italic> = 25.3%). Then, the fixed effect model was used and a significant difference was observed between the (TT+CT) genotype and breast cancer susceptibility (OR 0.906, 95% CI: 0.825–0.995, <italic>P</italic> = 0.039, <xref ref-type="fig" rid="pone-0070656-g002">Figure 2</xref>). No significant risk associations with breast cancer susceptibility were demonstrated for the other SNP genotypes.</p>
<fig id="pone-0070656-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0070656.g002</object-id><label>Figure 2</label><caption>
<title>Forest plot for the association between miR-196a2 polymorphism and breast cancer risk.</title>
<p>(Significant difference was observed for the comparison of miR-196a2 polymorphism (TT+CT) vs. CC using a fixed-effects model. OR, odds ratio; CI, confidence interval.)</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0070656.g002" position="float" xlink:type="simple"/></fig>
<p>Three studies of polymorphism rs3746444 in miR-499 were included in the meta-analysis. No significant risk associations with breast cancer susceptibility were revealed for any SNP of the miR-499 genotypes. No subgroup analysis was performed for the limited studies.</p>
<p>Significant heterogeneities in the data of miR-196a2 rs11614913 SNPs were observed in <xref ref-type="table" rid="pone-0070656-t002">Table 2</xref>. Then sources of this heterogeneity were evaluated systematically using meta-regression. The source of heterogeneity was found to be mainly related to the article publication year (t = 4.64, <italic>P</italic> = 0.004). Because the limit of the published article number, we did not perform the subgroup analysis by publication year.</p>
<p>All the results for the three SNPs in the miRNAs obstained from random model or fixed model were similar. No publication bias was found in this meta-analysis using Begg's (<italic>P</italic>&gt;0.05) and Egger's tests (<italic>P</italic>&gt;0.05).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>MiRNAs have been linked to the etiology, progression and prognosis of cancer <xref ref-type="bibr" rid="pone.0070656-Kumar1">[33]</xref>. The gain or loss of SNPs in miRNA genes often affect the targeting gene function through the transcription <xref ref-type="bibr" rid="pone.0070656-Ryan1">[12]</xref>. To date, many studies have investigated the roles of SNPs in miRNAs in breast cancer susceptibility <xref ref-type="bibr" rid="pone.0070656-Alshatwi1">[14]</xref>–<xref ref-type="bibr" rid="pone.0070656-Smith1">[18]</xref>, <xref ref-type="bibr" rid="pone.0070656-Zhang1">[22]</xref>, <xref ref-type="bibr" rid="pone.0070656-Garcia1">[31]</xref>, <xref ref-type="bibr" rid="pone.0070656-Zhang2">[34]</xref>, <xref ref-type="bibr" rid="pone.0070656-Zhong1">[35]</xref>. Among them, SNPs rs2910164 in miR-146a <xref ref-type="bibr" rid="pone.0070656-Lian1">[36]</xref>–<xref ref-type="bibr" rid="pone.0070656-Gao1">[38]</xref>, rs11614913 in miR-196-a2 <xref ref-type="bibr" rid="pone.0070656-Alshatwi1">[14]</xref>, <xref ref-type="bibr" rid="pone.0070656-Hu1">[17]</xref>, <xref ref-type="bibr" rid="pone.0070656-Wang1">[29]</xref>, <xref ref-type="bibr" rid="pone.0070656-Linhares2">[39]</xref>, <xref ref-type="bibr" rid="pone.0070656-Qiu1">[40]</xref> and rs3746444 in miR-499 <xref ref-type="bibr" rid="pone.0070656-Alshatwi1">[14]</xref>, <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>, <xref ref-type="bibr" rid="pone.0070656-Chen1">[41]</xref> are three SNPs that are commonly found in mature miRNA regions, which may contribute to breast cancer susceptibility. However, the results remain contradictory and inconclusive <xref ref-type="bibr" rid="pone.0070656-Alshatwi1">[14]</xref>, <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>, <xref ref-type="bibr" rid="pone.0070656-Jedlinski1">[20]</xref>, <xref ref-type="bibr" rid="pone.0070656-Garcia1">[31]</xref>. Therefore, in this meta-analysis, we further explored the associations of these three SNPs (in miR-146a, miR-196-a2 and miR-499) with breast cancer risk.</p>
<p>Polymorphism rs2910164 in miR-146a is located in the 3p strand and comprises a G to C change, which results in a change from a G∶U pair to a C∶U mismatch in the stem structure of the miR-146a precursor and alters the expression of mature miR-146a to influence cancer risk <xref ref-type="bibr" rid="pone.0070656-Akkiz1">[42]</xref>, <xref ref-type="bibr" rid="pone.0070656-Jazdzewski2">[43]</xref>. To further explore whether miR-146a rs2910164 is associated with breast cancer susceptibility, 4225 cases and 4469 controls are investigated for miR-146a rs2910164 in this meta-analysis. Our results failed to find an association between polymorphism rs2910164 in miR-146a and breast cancer risk, similar to other studies <xref ref-type="bibr" rid="pone.0070656-Wang2">[37]</xref>, <xref ref-type="bibr" rid="pone.0070656-Gao1">[38]</xref>, <xref ref-type="bibr" rid="pone.0070656-Wang3">[44]</xref>, but is different to Lian's report, which showed that increased risk of breast cancer was associated with the CC genotype of rs2910164 in miR-146a in Europeans <xref ref-type="bibr" rid="pone.0070656-Lian1">[36]</xref>. The difference between our study and Lian's study may be attributed to removing or taking the Italy population data in Catucci's study <xref ref-type="bibr" rid="pone.0070656-Catucci1">[19]</xref>. In our study, we found that the Italy population data in Catucci's study deviated from the HWE (<italic>P</italic> = 0.019) and removed this data from our meta-analysis. But, this data was calculated in Europeans in Lian's study <xref ref-type="bibr" rid="pone.0070656-Lian1">[36]</xref>.</p>
<p>Polymorphism rs11614913 in miR-196a2, which is located in the 3′ mature sequence of miR-196a2, may affect pre-miRNA maturation <xref ref-type="bibr" rid="pone.0070656-Ryan1">[12]</xref>, <xref ref-type="bibr" rid="pone.0070656-Hu1">[17]</xref>. Li <italic>et al.</italic> reported that the expression level of miR-196a was significantly higher in hepatocellular carcinoma patients with the CC genotype (or at least one C genotype) than in patients with the TT genotype <xref ref-type="bibr" rid="pone.0070656-Li1">[45]</xref>. Many studies showed that individuals carrying the CC genotype could suffer from significantly elevated the risk of breast cancer, lung cancer, gastric cancer, colorectal cancer and hepatocellular carcinoma compared to those with TT or TT+TC genotypes <xref ref-type="bibr" rid="pone.0070656-Wang3">[44]</xref>–<xref ref-type="bibr" rid="pone.0070656-Min1">[46]</xref>. When all eligible studies were pooled into this meta-analysis, no significantly increased breast cancer risk was found. After excluding the data in which genotype distribution in the controls deviated from the HWE, the heterogeneities were reduced, revealing an association of the CC genotype of miR-196a2 SNP with an increased breast cancer risk compared with the TT+CT genotypes, which was consistent with our previous finding <xref ref-type="bibr" rid="pone.0070656-Wang4">[47]</xref>. Our results provide the compelling evidence that polymorphism rs11614913 in miR-196a2 plays a crucial role in breast cancer development, and supports the view this SNP in miR-196a2 could be used as a candidate biomarker for the diagnosis of breast cancer risk.</p>
<p>Polymorphism rs3746444 in miR-499 involves an A to G nucleotide substitution, which leads to a change from an A∶U pair to a G∶U mismatch in the stem structure of the miR-499 precursor <xref ref-type="bibr" rid="pone.0070656-Xiang1">[48]</xref>. A number of case-control studies have investigated the association of SNP in miR-499 with cancer risk in multiple types of cancer <xref ref-type="bibr" rid="pone.0070656-Min1">[46]</xref>, <xref ref-type="bibr" rid="pone.0070656-Xiang1">[48]</xref>, <xref ref-type="bibr" rid="pone.0070656-Vinci1">[49]</xref>. However, only a few epidemiological studies focused on the association between polymorphisms rs3746444 in miR-499 and breast cancer risk. Our meta-analysis failed to discover an obvious association between rs3746444 in miR-499 and breast cancer risk. The exact roles of miR-499 SNPs in breast cancer risk require further studies.</p>
<p>Sample size is an important parameter for investigating the genetic effect of any SNP. Our meta-analysis provided higher and sufficient numbers of cases and controls than a single study, significantly increasing the statistical power. In addition, we assessed the qualities of the studies in this meta-analysis, which improved the reliability of the results.</p>
<p>Although meta-analysis is robust, there are still several limitations in this study. First, our study did not evaluate any potential gene-gene interaction and gene-environment interactions. Second, our analysis was based on English publications, which may have introduced a language bias. Last, a lack of sufficient eligible studies limited further subgroup analyses.</p>
<p>In conclusion, this study demonstrates that SNP rs11614913 in miR-196a2 plays a crucial role in the development of breast cancer. We found no significant associations of polymorphisms rs2910164 in miR-146 and rs3746444 in miR499 with breast cancer susceptibility. Well-designed studies with larger sample sizes are needed to confirm the roles of these miRNA polymorphisms in breast cancer risk.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0070656.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0070656.s001" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA 2009 Checklist for this Meta-analysis.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0070656-EsquelaKerscher1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Esquela-Kerscher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Slack</surname><given-names>FJ</given-names></name> (<year>2006</year>) <article-title>Oncomirs - microRNAs with a role in cancer</article-title>. <source>Nat Rev Cancer</source> <volume>6</volume>: <fpage>259</fpage>–<lpage>269</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Bartels1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bartels</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Tsongalis</surname><given-names>GJ</given-names></name> (<year>2009</year>) <article-title>MicroRNAs: novel biomarkers for human cancer</article-title>. <source>Clin Chem</source> <volume>55</volume>: <fpage>623</fpage>–<lpage>631</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Lu1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Getz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Miska</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Alvarez-Saavedra</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lamb</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>MicroRNA expression profiles classify human cancers</article-title>. <source>Nature</source> <volume>435</volume>: <fpage>834</fpage>–<lpage>838</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Rosenfeld1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosenfeld</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Aharonov</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Meiri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rosenwald</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Spector</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>MicroRNAs accurately identify cancer tissue origin</article-title>. <source>Nat Biotechnol</source> <volume>26</volume>: <fpage>462</fpage>–<lpage>469</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Berezikov1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berezikov</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Guryev</surname><given-names>V</given-names></name>, <name name-style="western"><surname>van de Belt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wienholds</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Plasterk</surname><given-names>RH</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Phylogenetic shadowing and computational identification of human microRNA genes</article-title>. <source>Cell</source> <volume>120</volume>: <fpage>21</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Pillai1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pillai</surname><given-names>RS</given-names></name> (<year>2005</year>) <article-title>MicroRNA function: multiple mechanisms for a tiny RNA</article-title>? <source>RNA</source> <volume>11</volume>: <fpage>1753</fpage>–<lpage>1761</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Zamore1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zamore</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Haley</surname><given-names>B</given-names></name> (<year>2005</year>) <article-title>Ribo-gnome: the big world of small RNAs</article-title>. <source>Science</source> <volume>309</volume>: <fpage>1519</fpage>–<lpage>1524</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Carthew1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carthew</surname><given-names>RW</given-names></name> (<year>2006</year>) <article-title>Gene regulation by microRNAs</article-title>. <source>Curr Opin Genet Dev</source> <volume>16</volume>: <fpage>203</fpage>–<lpage>208</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Calin1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Calin</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Ferracin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cimmino</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Di Leva</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia</article-title>. <source>N Engl J Med</source> <volume>353</volume>: <fpage>1793</fpage>–<lpage>1801</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Jazdzewski1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jazdzewski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Franssila</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jarzab</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schoenberg</surname><given-names>DR</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>105</volume>: <fpage>7269</fpage>–<lpage>7274</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Lin1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Horikawa</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tamboli</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Clague</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>CG</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma</article-title>. <source>Carcinogenesis</source> <volume>31</volume>: <fpage>1805</fpage>–<lpage>1812</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Ryan1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ryan</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Robles</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>CC</given-names></name> (<year>2010</year>) <article-title>Genetic variation in microRNA networks: the implications for cancer research</article-title>. <source>Nat Rev Cancer</source> <volume>10</volume>: <fpage>389</fpage>–<lpage>402</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Ye1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk</article-title>. <source>Cancer Prev Res (Phila)</source> <volume>1</volume>: <fpage>460</fpage>–<lpage>469</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Alshatwi1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alshatwi</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Shafi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hasan</surname><given-names>TN</given-names></name>, <name name-style="western"><surname>Syed</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Al-Hazzani</surname><given-names>AA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e30049</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Pastrello1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pastrello</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Polesel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Della Puppa</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Viel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maestro</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients</article-title>. <source>Carcinogenesis</source> <volume>31</volume>: <fpage>2124</fpage>–<lpage>2126</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Shen1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ambrosone</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>DiCioccio</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Odunsi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lele</surname><given-names>SB</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis</article-title>. <source>Carcinogenesis</source> <volume>29</volume>: <fpage>1963</fpage>–<lpage>1966</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Hu1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women</article-title>. <source>Hum Mutat</source> <volume>30</volume>: <fpage>79</fpage>–<lpage>84</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Smith1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Smith</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Jedlinski</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Gabrovska</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Weinstein</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Haupt</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A genetic variant located in miR-423 is associated with reduced breast cancer risk</article-title>. <source>Cancer Genomics Proteomics</source> <volume>9</volume>: <fpage>115</fpage>–<lpage>118</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Catucci1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Catucci</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Verderio</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pizzamiglio</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Heesen</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases</article-title>. <source>Hum Mutat</source> <volume>31</volume>: <fpage>E1052</fpage>–<lpage>1057</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Jedlinski1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jedlinski</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Gabrovska</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Weinstein</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Griffiths</surname><given-names>LR</given-names></name> (<year>2011</year>) <article-title>Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study</article-title>. <source>Twin Res Hum Genet</source> <volume>14</volume>: <fpage>417</fpage>–<lpage>421</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Greenland1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greenland</surname><given-names>S</given-names></name>, <name name-style="western"><surname>O'Rourke</surname><given-names>K</given-names></name> (<year>2001</year>) <article-title>On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions</article-title>. <source>Biostatistics</source> <volume>2</volume>: <fpage>463</fpage>–<lpage>471</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Zhang1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population</article-title>. <source>Eur J Cancer Care (Engl)</source> <volume>21</volume>: <fpage>274</fpage>–<lpage>280</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Vandenbroucke1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Von Elm</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Gotzsche</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Mulrow</surname><given-names>CD</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>[Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration]</article-title>. <source>Gac Sanit</source> <volume>23</volume>: <fpage>158</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Higgins1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Ioannidis1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ioannidis</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Patsopoulos</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Evangelou</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>Heterogeneity in meta-analyses of genome-wide association investigations</article-title>. <source>PLoS One</source> <volume>2</volume>: <fpage>e841</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Begg1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Egger1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Linhares1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Linhares</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Azevedo</surname><given-names>M</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Siufi</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>de Carvalho</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Wolgien</surname><given-names>MD</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer</article-title>. <source>BMC Med Genet</source> <volume>13</volume>: <fpage>119</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Wang1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>HQ</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>269</fpage>–<lpage>275</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Chu1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies</article-title>. <source>PLoS One</source> <volume>6</volume>: <fpage>e18108</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Garcia1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garcia</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Barjhoux</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Verny-Pierre</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Barnes</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The rs2910164:G&gt;C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers</article-title>. <source>Hum Mutat</source></mixed-citation>
</ref>
<ref id="pone.0070656-Hoffman1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoffman</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Leaderer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weidhaas</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis</article-title>. <source>Cancer Res</source> <volume>69</volume>: <fpage>5970</fpage>–<lpage>5977</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Kumar1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumar</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mercer</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Golub</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Jacks</surname><given-names>T</given-names></name> (<year>2007</year>) <article-title>Impaired microRNA processing enhances cellular transformation and tumorigenesis</article-title>. <source>Nat Genet</source> <volume>39</volume>: <fpage>673</fpage>–<lpage>677</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Zhang2"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>108</volume>: <fpage>13653</fpage>–<lpage>13658</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Zhong1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhong</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title>Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis</article-title>. <source>Mol Biol Rep</source> <volume>40</volume>: <fpage>3181</fpage>–<lpage>3186</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Lian1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lian</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans</article-title>. <source>PLoS One</source> <volume>7</volume>: <fpage>e31615</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Wang2"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Di</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>4571</fpage>–<lpage>4579</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Gao1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gao</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>XM</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>LJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis</article-title>. <source>Breast Cancer Res Treat</source> <volume>125</volume>: <fpage>571</fpage>–<lpage>574</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Linhares2"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Linhares</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Azevedo</surname><given-names>M</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Siufi</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>de Carvalho</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Wolgien Mdel</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer</article-title>. <source>BMC Med Genet</source> <volume>13</volume>: <fpage>119</fpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Qiu1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qiu</surname><given-names>LX</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Xi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>miR-196a2 C allele is a low-penetrant risk factor for cancer development</article-title>. <source>Cytokine</source> <volume>56</volume>: <fpage>589</fpage>–<lpage>592</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Chen1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>F</given-names></name> (<year>2012</year>) <article-title>miR-499 rs3746444 polymorphism is associated with cancer development among Asians and related to breast cancer susceptibility</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>10433</fpage>–<lpage>10438</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Akkiz1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akkiz</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bayram</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bekar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Akgollu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Uskudar</surname><given-names>O</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study</article-title>. <source>Gene</source> <volume>486</volume>: <fpage>104</fpage>–<lpage>109</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Jazdzewski2"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jazdzewski</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Liyanarachchi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Swierniak</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pachucki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ringel</surname><given-names>MD</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>106</volume>: <fpage>1502</fpage>–<lpage>1505</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Wang3"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies</article-title>. <source>Mutagenesis</source> <volume>27</volume>: <fpage>779</fpage>–<lpage>788</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Li1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>XD</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>ZG</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>XX</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CF</given-names></name> (<year>2010</year>) <article-title>A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis</article-title>. <source>Pathology</source> <volume>42</volume>: <fpage>669</fpage>–<lpage>673</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Min1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Min</surname><given-names>KT</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Jeon</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>SY</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Association of the miR-146aC&gt;G, 149C&gt;T, 196a2C&gt;T, and 499A&gt;G polymorphisms with colorectal cancer in the Korean population</article-title>. <source>Mol Carcinog</source> <volume>51 Suppl 1</volume>: <fpage>E65</fpage>–<lpage>73</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Wang4"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>B</given-names></name> (<year>2012</year>) <article-title>miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects</article-title>. <source>Exp Ther Med</source> <volume>3</volume>: <fpage>324</fpage>–<lpage>330</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Xiang1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>LP</given-names></name> (<year>2012</year>) <article-title>Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population</article-title>. <source>Mol Biol Rep</source> <volume>39</volume>: <fpage>7019</fpage>–<lpage>7023</lpage>.</mixed-citation>
</ref>
<ref id="pone.0070656-Vinci1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vinci</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gelmini</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pratesi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Conti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Malentacchi</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers</article-title>. <source>Clin Chem Lab Med</source> <volume>49</volume>: <fpage>2073</fpage>–<lpage>2080</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>